Institut National De La Sante Et De La Recherche Medicale

Université De Rouen Normandie

Université Paul Sabatier (toulouse Iii)

Universite Toulouse III – Paul Sabatier

Institut Natl Universitaire Jean-francois Champollion

Institut National Universitaire Jean-francois Champollion

Jérôme Leprince

Michel Treilhou

Bernard Pipy

Agnès Coste

Khaddouj Benmoussa

Elsa Bonnafe

The present invention relates to an isolated peptide consisting of a sequence of 3 to 39 amino acids derived from the amino acid sequence SEQ ID NO: 1, said peptide having a sequence of amino acids selected from the group consisting of:

Immunomodulatory peptide

Embodiments of the present disclosure relate to an isolated peptide consisting of a sequence of 3 to 39 amino acids derived from the amino acid sequence SEQ ID NO: 1, said peptide having a sequence of amino acids selected from the group consisting of: a) sequences of 3 to 39 amino acids comprising at least the residues 6 to 8 of SEQ ID NO: 1, and b) sequences of 3 to 39 amino acids having at least 70% identity with said sequence in a).

Growing community of inventors

Mont Saint Aignan, France

Jérôme Leprince